Medpace Holdings Inc
General ticker "MEDP" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $10.6B
Medpace Holdings Inc follows the US Stock Market performance with the rate: 20.2%.
Estimated limits based on current volatility of 2.3%: low 330.99$, high 346.39$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [260.53$, 371.86$]
- 2024-12-30 to 2025-12-30 estimated range: [280.05$, 399.77$]
Financial Metrics affecting the MEDP estimates:
- Positive: Non-GAAP EPS, $ of 8.88 > 2.29
- Positive: 9.05 < Operating profit margin, % of 17.86
- Positive: Return on assets ratio (scaled to [-100,100]) of 14.58 > 7.10
- Positive: -3.48 < Investing cash flow per share, $ of -1.13
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Negative: Operating cash flow per share per price, % of 4.88 <= 7.18
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
Short-term MEDP quotes
Long-term MEDP plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $1,142.38MM | $1,460.00MM | $1,885.84MM |
Operating Expenses | $943.76MM | $1,181.30MM | $1,549.02MM |
Operating Income | $198.62MM | $278.70MM | $336.82MM |
Non-Operating Income | $3.24MM | $4.16MM | $-1.14MM |
Interest Expense | $0.10MM | $2.90MM | $0.49MM |
Income(Loss) | $201.85MM | $282.86MM | $335.68MM |
Taxes | $20.00MM | $37.49MM | $52.87MM |
Profit(Loss) | $181.85MM | $245.37MM | $282.81MM |
Stockholders Equity | $952.93MM | $386.39MM | $558.95MM |
Assets | $1,659.93MM | $1,352.49MM | $1,656.83MM |
Operating Cash Flow | $263.33MM | $388.05MM | $433.37MM |
Capital expenditure | $28.27MM | $36.88MM | $36.65MM |
Investing Cash Flow | $-31.36MM | $-38.74MM | $-34.63MM |
Financing Cash Flow | $-44.45MM | $-775.77MM | $-182.64MM |
Earnings Per Share* | $5.06 | $7.57 | $9.20 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.